bench-to-bedside topline review for 2018: new targets and the ibd pipeline
Published 5 years ago • 431 plays • Length 19:28Download video MP4
Download video MP3
Similar videos
-
26:14
mechanisms of disease: unraveling the small molecule pipeline for ibd
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
20:05
ibd pathogenesis: personalizing targets
-
23:38
keynote lecture: treating to target in 2018: when and how to do it
-
12:48
ibd clinical update: new and emerging targeted therapies
-
10:22
sibo & ibs caused by vitamin deficiency?
-
6:07
high dose glutathione treats incurable disease - (real anti-aging)
-
7:08
joe rogan - gsp had ulcerative colitis during michael bisping fight
-
20:34
key insights: biosimilars and novel targets in ibd
-
28:54
treat to target in ibd
-
21:40
key insights in ibd: mastering clinical challenges & emerging therapies 2018
-
1:17
drive medical - deluxe aluminum bath bench and bath seat
-
29:01
case discussion ii: the biologically-experienced ibd patient
-
18:23
selection and use of the new and coming therapies for ibd? who? when? how?
-
15:56
therapeutic approaches to ibd in 2020 and beyond
-
20:39
the future of personalized ibd management: one size does not fit all
-
20:25
tight control and treat to target: how to assess the effectiveness of therapy
-
22:53
science of new and emerging ibd therapies: targeting treatment
-
21:36
keynote: evolution of disease management in ibd
-
24:18
optimizing therapy for mild to moderate ibd
-
17:44
implementing treatment pathways for the management of ulcerative colitis and crohn's disease